Impact of a false positive blood culture result on the management of febrile children. 1997

L C Thuler, and M Jenicek, and J P Turgeon, and M Rivard, and P Lebel, and M H Lebel
Department of Social and Preventive Medicine, Sainte-Justine Hospital, University of Montreal, Quebec, Canada.

OBJECTIVE To evaluate the impact of a preliminary positive blood culture result, subsequently confirmed to be a false positive blood culture result on rate of hospitalization, antibiotic therapy and use of microbiologic tests. METHODS Retrospective chart review. METHODS Children between 1 month and 18 years old on whom a blood culture was performed were eligible, excluding those with an underlying condition for whom a false positive blood culture may be difficult to assess. During the 1-year study period 9959 blood cultures were performed of which 778 (7.8%) produced growth. Charts of 81 patients with a false positive blood culture were reviewed and compared with those of 162 patients with a true negative blood culture. Patients already hospitalized when blood culture was drawn (n = 24) were analyzed separately from those who were not (n = 219). Among these, patients were divided into those who were followed as outpatients (n = 104) and hospitalized (n = 115). RESULTS Both groups (false positive vs. true negative) were comparable for age, sex, temperature at consultation, white blood cell count and illness severity. Twenty-six percent of patients followed as outpatients who had a false positive blood culture were hospitalized because of a preliminary positive blood culture result. Among patients hospitalized at the initial assessment, the frequency of antibiotic therapy (91% vs. 71%, P < 0.01), the frequency of use of intravenous antibiotics (80% vs. 58%, P < 0.01) and the percentage of unwarranted antibiotic prescription (13% vs. 0%, P < 0.01) were significantly greater in the false positive group than in the true negative group. The same results were found for each of these outcomes among the group of patients followed as outpatients (61% vs. 28%, P < 0.01, 17% vs. 0%, P < 0.01 and 39% vs. 0%, P < 0.01) for false positive vs. true negative, respectively. Patients with false positive blood cultures had more blood cultures drawn subsequently (P < 0.01). Children already hospitalized when the blood culture was obtained did not show significant differences in main outcomes. CONCLUSIONS False positive blood culture results generate unnecessary hospitalizations, antibiotic therapy and use of microbiologic tests.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D005260 Female Females

Related Publications

L C Thuler, and M Jenicek, and J P Turgeon, and M Rivard, and P Lebel, and M H Lebel
June 2015, Pain medicine (Malden, Mass.),
L C Thuler, and M Jenicek, and J P Turgeon, and M Rivard, and P Lebel, and M H Lebel
December 2021, Cureus,
L C Thuler, and M Jenicek, and J P Turgeon, and M Rivard, and P Lebel, and M H Lebel
August 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
L C Thuler, and M Jenicek, and J P Turgeon, and M Rivard, and P Lebel, and M H Lebel
January 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
L C Thuler, and M Jenicek, and J P Turgeon, and M Rivard, and P Lebel, and M H Lebel
February 1994, Pediatric emergency care,
L C Thuler, and M Jenicek, and J P Turgeon, and M Rivard, and P Lebel, and M H Lebel
August 2007, Pediatrics,
L C Thuler, and M Jenicek, and J P Turgeon, and M Rivard, and P Lebel, and M H Lebel
August 1988, The Medical journal of Australia,
L C Thuler, and M Jenicek, and J P Turgeon, and M Rivard, and P Lebel, and M H Lebel
October 1982, MMWR. Morbidity and mortality weekly report,
L C Thuler, and M Jenicek, and J P Turgeon, and M Rivard, and P Lebel, and M H Lebel
November 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
L C Thuler, and M Jenicek, and J P Turgeon, and M Rivard, and P Lebel, and M H Lebel
March 2022, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Copied contents to your clipboard!